TW271405B - - Google Patents

Info

Publication number
TW271405B
TW271405B TW082108415A TW82108415A TW271405B TW 271405 B TW271405 B TW 271405B TW 082108415 A TW082108415 A TW 082108415A TW 82108415 A TW82108415 A TW 82108415A TW 271405 B TW271405 B TW 271405B
Authority
TW
Taiwan
Prior art keywords
ranitidine
advantage
treatment
relates
present
Prior art date
Application number
TW082108415A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of TW271405B publication Critical patent/TW271405B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
TW082108415A 1992-10-13 1993-10-12 TW271405B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929221414A GB9221414D0 (en) 1992-10-13 1992-10-13 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
TW271405B true TW271405B (zh) 1996-03-01

Family

ID=10723323

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082108415A TW271405B (zh) 1992-10-13 1993-10-12

Country Status (25)

Country Link
US (1) US5593685A (zh)
EP (2) EP0664697B1 (zh)
JP (1) JP2918691B2 (zh)
KR (1) KR950703327A (zh)
AT (1) ATE166572T1 (zh)
AU (1) AU676690B2 (zh)
BG (1) BG99567A (zh)
CA (1) CA2147000A1 (zh)
CZ (1) CZ94495A3 (zh)
DE (1) DE69318844T2 (zh)
ES (1) ES2117718T3 (zh)
GB (1) GB9221414D0 (zh)
HU (2) HUT72497A (zh)
IL (1) IL107255A (zh)
MX (1) MX9306333A (zh)
NO (1) NO951432L (zh)
NZ (1) NZ256681A (zh)
OA (1) OA10144A (zh)
PH (1) PH31433A (zh)
PL (1) PL174359B1 (zh)
SG (1) SG49850A1 (zh)
SK (1) SK48395A3 (zh)
TW (1) TW271405B (zh)
WO (1) WO1994008560A1 (zh)
ZA (1) ZA937544B (zh)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
GB9418530D0 (en) * 1994-09-14 1994-11-02 Glaxo Group Ltd Medicaments
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
WO1997016159A1 (en) * 1995-10-30 1997-05-09 Warner-Lambert Company Enhanced anti-inflammatory oral composition containing h2 receptor antagonist and antimicrobial oils
DE19639343C2 (de) 1996-09-25 1998-10-08 Suedzucker Ag Komprimate, enthaltend ein Süßungsmittelgemisch
GB9715423D0 (en) * 1997-07-23 1997-09-24 Glaxo Group Ltd Aqueous compositions
US6086920A (en) * 1998-08-12 2000-07-11 Fuisz Technologies Ltd. Disintegratable microspheres
US6586023B1 (en) 1998-12-15 2003-07-01 Wm. Wrigley Jr. Company Process for controlling release of active agents from a chewing gum coating and product thereof
US6531114B1 (en) 1999-04-06 2003-03-11 Wm. Wrigley Jr. Company Sildenafil citrate chewing gum formulations and methods of using the same
US6627234B1 (en) 1998-12-15 2003-09-30 Wm. Wrigley Jr. Company Method of producing active agent coated chewing gum products
US7163705B2 (en) * 1998-12-15 2007-01-16 Wm. Wrigley Jr. Company Coated chewing gum product and method of making
US6270807B1 (en) 1999-03-02 2001-08-07 L. Perrigo Company Taste-masked pharmaceutical composition
US6773716B2 (en) 1999-04-06 2004-08-10 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US6426090B1 (en) * 1999-04-06 2002-07-30 Wm. Wrigley Jr. Company Over-coated product including tableted center and medicament
US20020159956A1 (en) * 1999-04-06 2002-10-31 Ream Ronald L. Over-coated chewing gum formulations
US6355265B1 (en) 1999-04-06 2002-03-12 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US7935362B2 (en) * 1999-04-06 2011-05-03 Wm. Wrigley Jr. Company Over-coated product including consumable center and medicament
US6322806B1 (en) 1999-04-06 2001-11-27 Wm. Wrigley Jr. Company Over-coated chewing gum formulations including tableted center
US6569472B1 (en) 2000-09-01 2003-05-27 Wm. Wrigley Jr. Company Coated chewing gum products containing antacid and method of making
US6541048B2 (en) 1999-09-02 2003-04-01 Wm. Wrigley Jr. Company Coated chewing gum products containing an acid blocker and process of preparing
US6663849B1 (en) 2000-09-01 2003-12-16 Wm. Wrigley Jr. Company Antacid chewing gum products coated with high viscosity materials
US6645535B2 (en) 1999-09-02 2003-11-11 Wm. Wrigley Jr. Company Method of making coated chewing gum products containing various antacids
US6491540B1 (en) * 1999-09-20 2002-12-10 Jack Barreca Center-filled supplement gum
US9253991B2 (en) 1999-09-20 2016-02-09 Jack Barreca Chewing gum with B vitamins
US9387168B2 (en) 1999-09-20 2016-07-12 Jack Barreca Chewing gum with tomatidine
US6572900B1 (en) 2000-06-09 2003-06-03 Wm. Wrigley, Jr. Company Method for making coated chewing gum products including a high-intensity sweetener
US7115288B2 (en) * 2000-06-09 2006-10-03 Wm. Wrigley Jr. Company Method for making coated chewing gum products with a coating including an aldehyde flavor and a dipeptide sweetener
US6444241B1 (en) 2000-08-30 2002-09-03 Wm. Wrigley Jr. Company Caffeine coated chewing gum product and process of making
US6579545B2 (en) 2000-12-22 2003-06-17 Wm. Wrigley Jr. Company Coated chewing gum products containing an antigas agent
JP5412966B2 (ja) * 2009-06-08 2014-02-12 ライオン株式会社 粒状製剤
CN109010303B (zh) * 2017-06-09 2021-05-07 苏州科伦药物研究有限公司 一种盐酸雷尼替丁胶囊的工业制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE82680T1 (de) * 1988-05-04 1992-12-15 Smith Kline French Lab Kautablette.
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it
NL8902338A (nl) * 1988-09-20 1990-04-17 Glaxo Group Ltd Farmaceutische preparaten.
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
NZ235877A (en) * 1989-11-02 1992-09-25 Mcneil Ppc Inc Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence
US5075114A (en) * 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
CA2052679C (en) * 1990-08-30 1997-12-02 Edward J. Roche Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
SK121193A3 (en) * 1991-04-04 1994-07-06 Procter & Gamble Chewable antacid compositions
EP0578768B1 (en) * 1991-04-04 1995-09-27 The Procter & Gamble Company Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress
DK0587744T3 (da) * 1991-05-28 2003-10-20 Mcneil Ppc Inc Tygbar sammensætning til frigørelse af et lægemiddel
CA2068402C (en) * 1991-06-14 1998-09-22 Michael R. Hoy Taste mask coatings for preparation of chewable pharmaceutical tablets
CA2079934C (en) * 1991-10-15 2002-09-03 Edward J. Roche Taste mask coatings for preparing chewable pharmaceutical tablets
US5229137A (en) * 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn

Also Published As

Publication number Publication date
US5593685A (en) 1997-01-14
EP0788789A1 (en) 1997-08-13
SG49850A1 (en) 1998-06-15
ES2117718T3 (es) 1998-08-16
SK48395A3 (en) 1995-11-08
DE69318844T2 (de) 1998-10-15
HUT72497A (en) 1996-05-28
AU676690B2 (en) 1997-03-20
ATE166572T1 (de) 1998-06-15
JPH08502272A (ja) 1996-03-12
AU5143493A (en) 1994-05-09
HU211847A9 (en) 1995-12-28
OA10144A (en) 1996-12-18
MX9306333A (es) 1995-01-31
PH31433A (en) 1998-11-03
CA2147000A1 (en) 1994-04-28
PL174359B1 (pl) 1998-07-31
IL107255A (en) 1998-07-15
GB9221414D0 (en) 1992-11-25
NO951432D0 (no) 1995-04-12
NO951432L (no) 1995-05-12
EP0664697B1 (en) 1998-05-27
HU9501053D0 (en) 1995-06-28
EP0664697A1 (en) 1995-08-02
WO1994008560A1 (en) 1994-04-28
ZA937544B (en) 1994-04-21
KR950703327A (ko) 1995-09-20
PL308356A1 (en) 1995-07-24
BG99567A (en) 1995-12-29
CZ94495A3 (en) 1995-10-18
IL107255A0 (en) 1994-01-25
NZ256681A (en) 1997-10-24
DE69318844D1 (de) 1998-07-02
JP2918691B2 (ja) 1999-07-12

Similar Documents

Publication Publication Date Title
TW271405B (zh)
EP0363415A4 (en) Compounds for the treatment of alzheimer's disease
HK1011987A1 (en) Sulfonamidocarbonylpyridine-2-carboxamides and their use as medicines
GR3002022T3 (en) 3,5-disubstituted 4,5-dihydroisoxazoles as transglutaminase inhibitors
EP0258390A4 (en) TREATMENT OF HYPERPROLIFERATIVE DERMATOS BY MANOALIDE.
EP0304221A3 (en) 5-amino or substituted amino 1,2,3-triazoles useful as antiproliferative agents
EP0328634A4 (en) Pharmaceutical compositions for the treatment of psoriasis
HUT47427A (en) Bezafibrat for treating diabetes
AU1146083A (en) 2,3-diaryl-5-halo thiophenes
TW267161B (zh)
EP0435177A3 (en) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
PH24094A (en) 5-aryl-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
DE3565210D1 (en) Composition for prevention and treatment of mycoplasmal pneumonia
GB8705459D0 (en) Treatment of peptic ulcers
GR853017B (zh)
GB2231059B (en) Treatment of hydrocarbon-in-water emulsions
PHUM6382Z (en) Composition for the treatment of pimples
GB9125670D0 (en) Treatment of neurogical conditions